secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kenvue Inc. (KVUE)
CIK:        0001944048
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001944048-24-000150
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kenvue Q3 net sales -0.4% to $3.9B, adj EPS $0.28 vs $0.31 YoY, lowers sales growth guidance
--------------------------------------------------------------------------------

- Net sales $3.9B, -0.4% YoY; organic growth +0.9% (value realization +2.5%, volume -1.6%).
- Diluted EPS $0.20; adjusted diluted EPS $0.28 vs $0.31 YoY; gross margin expanded 100bps to 58.5%.
- Self Care drove share gains; Essential Health broad-based growth; Skin Health and Beauty early recovery signs.
- 2024 outlook: net sales & organic growth guidance lowered to low end of ranges (1-3% & 2-4%); adj EPS reaffirmed $1.10-$1.20.
- Adjusted operating margin 22.1% vs 23.3% YoY due to increased brand investment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1944048/000194404824000150/0001944048-24-000150-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1944048/000194404824000150/kvue-20241107.htm
  HTML page:      https://secwatch.observer/filing/0001944048-24-000150

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer